CIPLA
Back to Cashflow Statement
|
CIPLA Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-2,326 Cr | ₹-3,691 Cr | ₹-2,988 Cr | ₹-2,389 Cr | ₹-1,872 Cr |
What is the latest Cash Flow from Investing Activities ratio of CIPLA ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2026 | ₹-2,326 Cr |
| Mar2025 | ₹-3,691 Cr |
| Mar2024 | ₹-2,988 Cr |
| Mar2023 | ₹-2,389 Cr |
| Mar2022 | ₹-1,872 Cr |
How is Cash Flow from Investing Activities of CIPLA Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-2,326 Cr | Negative | |
| Mar2025 | ₹-3,691 Cr | Negative | |
| Mar2024 | ₹-2,988 Cr | Negative | |
| Mar2023 | ₹-2,389 Cr | Negative | |
| Mar2022 | ₹-1,872 Cr | - | |
Compare Cash Flow from Investing Activities of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹111,571.0 Cr | 1.6% | -3.2% | -11.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,437.0 Cr | -0.5% | -3% | 16% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,054.0 Cr | 1.6% | 9.3% | 54.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,842.0 Cr | 3.5% | 2.3% | 40.6% | Stock Analytics | |
| MANKIND PHARMA | ₹102,410.0 Cr | 10.3% | 4.5% | -5.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,163.0 Cr | 5.8% | 3.2% | -8.3% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 1.6% |
-3.2% |
-11.1% |
| SENSEX | 0.7% |
-3.9% |
-8.9% |
You may also like the below Video Courses